Soliton Inc, a medical device company with a novel and proprietary platform technology, announces that the company’s Rapid Acoustic Pulse (RAP) device received the Best New Technology Award from the Aesthetic Industry Association (AIA).

The Soliton RAP device uses proprietary design acoustic shockwaves to mechanically disrupt targeted cellular structures in a completely non-invasive therapy. The clinically proven Rapid Acoustic Pulse (RAP) device was recently cleared by the FDA for temporary improvement in the appearance of cellulite. It had been previously cleared as an accessory to the 1064 nm Q-Switched laser for black ink tattoo removal in Fitzpatrick Skin Type I-III patients.

“We are honored to be the first recipient of this award from the Aesthetic Industry Association. We are thrilled to have our innovative technology recognized in this manner by industry peers and leaders. We are excited to further demonstrate the benefits of the RAP device to the AIA audience that includes physicians in the aesthetic industry and patients interested in tattoo removal and cellulite appearance reduction.”

— Brad Hauser, Soliton CEO and President

[Source(s): Soliton Inc, PR Newswire]